期刊
JOURNAL OF INTERNAL MEDICINE
卷 273, 期 1, 页码 31-41出版社
WILEY
DOI: 10.1111/joim.12001
关键词
atrial fibrillation; guidelines; prevention; risk factors; stroke
资金
- Boehringer Ingelheim
John Camm A (St George's University of London, London, UK). Managing anticoagulation for atrial fibrillation: current issues and future strategies (Review). J Intern Med 2013; 273: 31-41. Although warfarin is superior to aspirin in reducing the risk of stroke in patients with atrial fibrillation, it can increase major bleeds. Hence, physicians stratify patients according to stroke risk to ensure a net benefit. In this review, the CHA2DS2-VASc stratification scheme used in the latest European Society of Cardiology (2010/12) guidelines will be explained. The greater sensitivity of this scheme, compared to the previous CHADS2, more closely delineates patients for whom warfarin is appropriate. The review also anticipates that there will be a wider range of patients who may benefit from the new oral anticoagulants, which show similar or superior efficacy and/or safety to warfarin with a significant reduction in intracranial haemorrhage and do not require routine coagulation monitoring. The role of conventional and new anticoagulant options will also be discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据